PharmaTher Announces FDA Acceptance, As a Priority Original Abbreviated New Drug Application, for KETARX™ (Ketamine) Post published:September 27, 2023 Post category:Press Release
Small Pharma Reports Positive Top-line Data from SPL026 (DMT)-SSRI Drug Interaction Study in Patients with Major Depressive Disorder Post published:September 26, 2023 Post category:Press Release
Numinus Wellness Inc. Announces At-The-Market Offering Equity Program Post published:September 26, 2023 Post category:Press Release
Gilgamesh Pharmaceuticals Successfully Completes Phase 1 SAD/MAD Clinical Trials of GM-1020 Post published:September 21, 2023 Post category:Press Release
Transcend Therapeutics and Yale awarded U.S. Department of Defense grant to study methylone for PTSD Post published:September 21, 2023 Post category:Press Release
FILAMENT HEALTH AND JAGUAR HEALTH JOINT VENTURE MAGDALENA BIOSCIENCES COMPLETES IMPORT OF COCA LEAF FROM PERU Post published:September 21, 2023 Post category:Press Release
Silo Pharma Announces Positive Data on SPC-15 for PTSD and Prepares to File Pre-Investigational New Drug (IND) Application with FDA Post published:September 20, 2023 Post category:Press Release
Numinus Congratulates MAPS on its Phase 3 Study Results Published in Nature Medicine Post published:September 19, 2023 Post category:Press Release
Numinus Takes Actions to Accelerate its Path to Profitability by Focusing on Positive Cash Flow Generating Operations Post published:September 19, 2023 Post category:Press Release
COMPASS Pathways appoints Daphne Karydas to its Board of Directors Post published:September 19, 2023 Post category:Press Release